Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04063592

AMI Construction in Lower Extremity Residual Limbs

A Novel Approach to Lower Extremity Residual Limb Revision to Augment Volitional Motor Control, Restore Proprioception and Reverse Limb Atrophy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
26 (estimated)
Sponsor
Brigham and Women's Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study will involve the development of a novel approach to lower extremity residual limb surgical revision that offers the promise of augmenting volitional motor control, restore proprioception and reverse atrophy

Detailed description

The hypothesis of this research protocol is that we will be able to modify the residual limbs of patients who have already undergone lower extremity amputations so as to include biological actuators that will enable the successful employment of next generation lower extremity prostheses, diminish/eliminate phantom limb pain, restore proprioception and regenerate lost muscle mass. The specific aims of the project are as follows: 1. To develop a standardized operative technique for both above knee (AK) and below knee (BK) amputation revision procedures that includes AMIs to restore musculotendinous proprioceptive capabilities 2. To assess the capacity for these actuators to provide enhanced motor control and sensory feedback, as well as ablate phantom limb symptomatology and augment residual limb muscle mass 3. To determine the reinnervation time course and longevity of these biological constructs 4. To validate the functional and somatosensory superiority of the proposed revision technique over standard approaches to BKA and AKA 5. To develop a modified acute postoperative rehabilitation strategy suited to this new surgical approach

Conditions

Interventions

TypeNameDescription
PROCEDUREResidual limb revisionSurgical procedure involving construction of agonist-antagonist myoneural interfaces (AMIs)

Timeline

Start date
2020-02-24
Primary completion
2026-09-30
Completion
2026-09-30
First posted
2019-08-21
Last updated
2025-10-20

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04063592. Inclusion in this directory is not an endorsement.